Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern
Kamiya, O.; Hoshino, A.; Ohara, K.; Nagata, K.; Ono, Y.; Saito, M.; Itou, T.; Yamamoto, K.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(4 Part 1): 863-865
1989
ISSN/ISBN: 0385-0684
PMID: 2469398
Accession: 039604248
PDF emailed within 1 workday: $29.90
Related References
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273Imamura, Y.; Takagi, T.; Yawata, Y.; Nishinarita, S.; Kosaka, M.; Mikuni, C.; Takatsuki, K.; Sezaki, T.; Mori, M.; Tsuchiya, J. 1994: Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group International Journal of Hematology 59(2): 113-123
Glueck, S.; Schoppe, W.D.; Schneider, W. 1986: Vincristine cyclophosphamide melphalan prednisolone chemotherapy of multiple myeloma after ineffective melphalan prednisolone therapy Blut 53(3): 227
Ishii, H. 1988: Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine Acta Medica Okayama 42(3): 175-182
Takagi, T.; Oguro, M.; Sakai, C. 1986: Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma Japanese Journal of Clinical Hematology 27(12): 2249-2253
Suzuki, K.; Doki, N.; Meguro, K.; Sunami, K.; Kosugi, H.; Sasaki, O.; Takagi, T.; Murakami, H.; Shimizu, K. 2019: Report of phase I and II trials of melphalan, prednisolone, and thalidomide triplet combination therapy versus melphalan and prednisolone doublet combination therapy in Japanese patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplantation International Journal of Hematology 110(4): 447-457
Gregory, W.M.; Richards, M.A.; Malpas, J.S. 1992: Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 10(2): 334-342
Adachi, T.; Asano, K.; Sezaki, T.; Takahashi, I.; Kimura, I. 1982: Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide: MIP combination chemotherapy Acta Medica Okayama 36(1): 39-47
Majumdar, G.; Ganguly, K.; Kashyap, S.; Bardhan, G. 1998: Cyclophosphamide-idarubicin-dexamethasone An effective oral combination chemotherapy for melphalan-prednisolone resistant multiple myeloma British Journal of Haematology 102(1): 352
Sezaki, T.; Ishii, H.; Osada, T.; Adachi, T.; Takahashi, I.; Ohnoshi, T.; Kimura, I. 1982: Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone Japanese Journal of Clinical Hematology 23(6): 847-853
Keldsen, N.; Bjerrum, O.W.; Dahl, I.M.; Drivsholm, A.; Ellegaard, J.; Gadeberg, O.; Gimsing, P.; Grønvold, T.; Hansen, M.M.; Hippe, E. 1993: Multiple myeloma treated with mitoxantrone in combination with vincristine and prednisolone (NOP regimen) versus melphalan and prednisolone: a phase IIi study. Nordic Myeloma Study Group (NMSG) European Journal of Haematology 51(2): 80-85
Adachi, T.; Asano, K.; Sezaki, T.; Takahashi, I.; Kimura, I. 1982: Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide prednisolone and sequential melphalan and ifosfamide combination chemo therapy Acta Medica Okayama 36(1): 39-48
Takenaka, T.; Itoh, K.; Suzuki, T.; Utsunomiya, A.; Matsuda, S.; Chou, T.; Sai, T.; Sano, M.; Konda, S.; Ohno, T.; Mikuni, C.; Deura, K.; Yamada, T.; Mizorogi, F.; Nagoshi, H.; Tomonaga, M.; Hotta, T.; Kawano, K.; Tsushita, K.; Hirano, M.; Shimoyama, M. 2004: Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301 International Journal of Hematology 79(2): 165-173
Takagi, T.; Sakai, C.; Goto, S. 1996: MCNU-VMP therapy A new nitrosourea-based combination chemotherapy for multiple myeloma British Journal of Haematology 93(Suppl 2): 302
Chou, T.; Tobinai, K.; Uike, N.; Asakawa, T.; Saito, I.; Fukuda, H.; Mizoroki, F.; Ando, K.; Iida, S.; Ueda, R.; Tsukasaki, K.; Hotta, T.; Aikawa, K.; Matsuda, S.; Nakata, M.; Oshimi, K.; Ohmachi, K.; Ohnishi, K.; Kinoshita, T.; Okamura, S.; Tsukada, J. 2011: Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112 Japanese Journal of Clinical Oncology 41(4): 586-589